Observed differences in mucin gene expression and relative C. difficile adhesion between healthy and infected populations suggest that further investigation of microbe-mucus interactions may elucidate novel targets for therapeutic development in the treatment of CDI. Here, MUC5AC is linked to clostridium difficile infection.